Physician profile
Sunil Saith
NPI 1891921037
$213,232.74
in general payments reported to CMS, 2019-2025
35 companies · $11K in 2025
The $11K reported for 2025 was more than what 99% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $57K · 2021: $91K · 2022: $1,338 · 2023: $2,705 · 2024: $17K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $18K · Food and Beverage: $7,948 · Consulting Fee: $3,600 · Grant: $1,063 · Education: $480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $17,724.16 |
| Food and Beverage | $7,947.78 |
| Consulting Fee | $3,600.00 |
| Grant | $1,063.30 |
| Education | $479.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $185,937.36 | 2019-2025 | |
| Philips North America LLC | $15,894.49 | 2024-2025 | (9520) Igt Devices Undivided, Igt Devices Undivided, US Eq Undivided |
| Abbott Laboratories | $2,101.83 | 2021-2025 | Optis, Cardiomems, Aveir |
| Boston Scientific Corporation | $1,779.83 | 2023-2024 | Avvigo Guidance System, Rotapro |
| Janssen Pharmaceuticals, INC | $838.93 | 2022-2024 | Xarelto |
| Medtronic, INC. | $740.77 | 2023-2024 | Onyx Frontier, Symplicity G3, Corevalve Evolut R |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $537.61 | 2021-2025 | Lifevest |
| Irhythm Technologies, INC. | $525.85 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Inari Medical, INC. | $456.19 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Alnylam Pharmaceuticals INC. | $440.96 | 2022-2024 | Amvuttra |
| Abiomed | $393.64 | 2023-2025 | Impella |
| Shockwave Medical, INC | $343.18 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Merck Sharp & Dohme LLC | $317.83 | 2021-2024 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $317.37 | 2022-2024 | Camzyos |
| Kestra Medical Technology Services, INC. | $301.09 | 2023-2025 | Assure Wcd |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $263.17 | 2021-2024 | Brilinta, Farxiga |
| Nuwellis, INC. | $236.63 | 2022 | |
| Scpharmaceuticals INC. | $230.05 | 2024-2025 | |
| Chiesi USA, INC. | $186.67 | 2023-2024 | Kengreal |
| Atricure, INC. | $184.11 | 2021 | |
| Astellas Pharma US INC | $152.46 | 2021-2022 | |
| Cordis US Corp. | $149.38 | 2021-2022 | |
| Penumbra, INC. | $141.22 | 2024 | Indigo System |
| Kiniksa Pharmaceuticals, LTD. | $133.57 | 2023 | Arcalyst |
| Stryker Corporation | $126.07 | 2025 | Flowtriever |
| Biotronik INC. | $114.83 | 2021 | |
| Haemonetics Corporation | $101.56 | 2023 | |
| Angiodynamics, INC. | $56.85 | 2025 | Alphavac |
| Cook Medical LLC | $52.63 | 2025 | Zilver Ptx |
| Actelion Pharmaceuticals US, INC. | $51.77 | 2023 | Opsumit, Uptravi |
| Lexicon Pharmaceuticals, INC. | $40.38 | 2024 | Inpefa |
| Bayer Healthcare Pharmaceuticals INC. | $27.14 | 2024 | |
| Biosense Webster, INC. | $22.46 | 2024 | Carto 3 |
| United Therapeutics Corporation | $21.62 | 2023 | Orenitram, Tyvaso |
| Lundbeck LLC | $13.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Saith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.